Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 429

1.

Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).

Hidalgo-Tenorio C, Ramírez-Taboada J, Gil-Anguita C, Esquivias J, Omar-Mohamed-Balgahata M, SamPedro A, Lopez-Ruz M, Pasquau J.

AIDS Res Ther. 2017 Jul 18;14(1):34. doi: 10.1186/s12981-017-0160-0.

2.

Impact of GP reminders on follow-up of abnormal cervical cytology: a before-after study in Danish general practice.

Kristiansen BK, Andersen B, Bro F, Svanholm H, Vedsted P.

Br J Gen Pract. 2017 Aug;67(661):e580-e587. doi: 10.3399/bjgp17X691913. Epub 2017 Jul 17.

PMID:
28716995
3.

Analytic and Diagnostic Performances of Human Papillomavirus E6/E7 mRNA Test on up-to 11-Year-Old Liquid-Based Cervical Samples. A Biobank-Based Longitudinal Study.

Zappacosta R, Sablone F, Pansa L, Buca D, Buca D, Rosini S.

Int J Mol Sci. 2017 Jul 11;18(7). pii: E1480. doi: 10.3390/ijms18071480.

4.

Yield of Cytology Surveillance After High-Grade Vulvar Intraepithelial Neoplasia or Cancer.

Kuroki LM, Frolova AI, Wu N, Liu J, Powell M, Thaker PH, Massad LS.

J Low Genit Tract Dis. 2017 Jul;21(3):193-197. doi: 10.1097/LGT.0000000000000321.

PMID:
28644191
5.

Human Papillomavirus Genotype Distribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings.

Nah EH, Cho S, Kim S, Cho HI.

Ann Lab Med. 2017 Sep;37(5):426-433. doi: 10.3343/alm.2017.37.5.426.

6.

Sexually Transmitted Infections: A Novel Screening Strategy for Improving Women's Health in Vulnerable Populations.

Frati ER, Fasoli E, Martinelli M, Colzani D, Bianchi S, Carnelli L, Amendola A, Olivani P, Tanzi E.

Int J Mol Sci. 2017 Jun 20;18(6). pii: E1311. doi: 10.3390/ijms18061311.

7.

"Low-grade squamous intraepithelial lesion, cannot exclude high-grade:" TBS says "Don't Use It!" should I really stop it?

Chiaffarano JM, Alexander M, Rogers R, Zhou F, Cangiarella J, Yee-Chang M, Elgert P, Simsir A.

Cytojournal. 2017 May 26;14:13. doi: 10.4103/cytojournal.cytojournal_48_16. eCollection 2017.

9.

Epidemiological investigation of the relationship between common lower genital tract infections and high-risk human papillomavirus infections among women in Beijing, China.

Zhang D, Li T, Chen L, Zhang X, Zhao G, Liu Z.

PLoS One. 2017 May 22;12(5):e0178033. doi: 10.1371/journal.pone.0178033. eCollection 2017.

10.

Risk factors for cervical intraepithelial neoplasia and cervical cancer in Chinese women: large study in Jiexiu, Shanxi Province, China.

Wang Z, Wang J, Fan J, Zhao W, Yang X, Wu L, Li D, Ding L, Wang W, Xu J, Stram M, Zhao C, Hao M.

J Cancer. 2017 Mar 12;8(6):924-932. doi: 10.7150/jca.17416. eCollection 2017.

11.

Evaluation of microRNA-205 expression as a potential triage marker for patients with low-grade squamous intraepithelial lesions.

Xie H, Norman I, Hjerpe A, Vladic T, Larsson C, Lui WO, Östensson E, Andersson S.

Oncol Lett. 2017 May;13(5):3586-3598. doi: 10.3892/ol.2017.5909. Epub 2017 Mar 24.

12.

Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.

Guo M, Khanna A, Wang J, Dawlett MA, Kologinczak TL, Lyons GR, Bassett RL Jr, Sneige N, Gong Y, Bevers TB.

Cancer. 2017 Aug;125(8):644-651. doi: 10.1002/cncy.21877. Epub 2017 May 12.

PMID:
28498639
13.

The prevalence and course of preinvasive cervical lesions during pregnancy in a Northern Nigerian Teaching Hospital.

Bakari F, Abdul MA, Ahmed SA.

Ann Afr Med. 2017 Apr-Jun;16(2):74-80. doi: 10.4103/aam.aam_35_16.

14.

Ellagic acid and Annona muricata in the chemoprevention of HPV-related pre-neoplastic lesions of the cervix.

Morosetti G, Criscuolo AA, Santi F, Perno CF, Piccione E, Ciotti M.

Oncol Lett. 2017 Mar;13(3):1880-1884. doi: 10.3892/ol.2017.5634. Epub 2017 Jan 23.

15.

Clinical analysis of cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia.

He Y, Zhao Q, Geng YN, Yang SL, Yin CH, Wu YM.

Medicine (Baltimore). 2017 Apr;96(17):e6700. doi: 10.1097/MD.0000000000006700.

16.

Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country.

Maza M, Alfaro K, Garai J, Velado MM, Gage JC, Castle PE, Felix J, Luciani S, Campos N, Kim J, Masch R, Cremer M.

Gynecol Oncol Rep. 2017 Mar 3;20:58-61. doi: 10.1016/j.gore.2017.02.011. eCollection 2017 May.

17.

Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach.

Robbins HA, Strickler HD, Massad LS, Pierce CB, Darragh TM, Minkoff H, Keller MJ, Fischl M, Palefsky J, Flowers L, Rahangdale L, Milam J, Shrestha S, Colie C, DʼSouza G.

AIDS. 2017 Apr 24;31(7):1035-1044. doi: 10.1097/QAD.0000000000001450.

PMID:
28323758
18.

Diagnostic accuracy of oral cancer cytology in a pilot study.

Sekine J, Nakatani E, Hideshima K, Iwahashi T, Sasaki H.

Diagn Pathol. 2017 Mar 16;12(1):27. doi: 10.1186/s13000-017-0618-3.

19.

Prognostic value of human papillomavirus 16/18 genotyping in low-grade cervical lesions preceded by mildly abnormal cytology.

Ye J, Cheng B, Cheng YF, Yao YL, Xie X, Lu WG, Cheng XD.

J Zhejiang Univ Sci B. 2017 Mar.;18(3):249-255. doi: 10.1631/jzus.B1600473.

20.

Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana.

Obiri-Yeboah D, Adu-Sarkodie Y, Djigma F, Akakpo K, Aniakwa-Bonsu E, Amoako-Sakyi D, Jacques S, Mayaud P.

Gynecol Oncol Res Pract. 2017 Mar 3;4:5. doi: 10.1186/s40661-017-0041-1. eCollection 2017. Erratum in: Gynecol Oncol Res Pract. 2017 Mar 23;4:8.

Supplemental Content

Support Center